Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.

@article{Bellmann2017LeftAA,
  title={Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome.},
  author={Barbara Bellmann and Steffen Schnupp and Peter K{\"u}hnlein and Christian Javernik and Caroline Kleinecke and Andreas Rillig and Ulf Landmesser and Johannes Brachmann and J W Park},
  journal={Journal of cardiovascular electrophysiology},
  year={2017},
  volume={28 3},
  pages={315-320}
}
AIMS Percutaneous left atrial appendage closure (LAAC) is a valuable treatment option for stroke prevention in patients with atrial fibrillation and a HAS-BLED-Score ≥3. Determinants of procedural safety events and neurological outcome of the patients with the Occlutech device (OD) are not established yet. METHODS AND RESULTS Between 2012 and 2016, 30… CONTINUE READING